Lyell Immunopharma Stock Forecast

Hold candidate since Jul 02, 2026

The Lyell Immunopharma, Inc. stock price gained 8.33% on the last trading day (Thursday, 2nd Jul 2026), rising from $12.97 to $14.05. During the last trading day the stock fluctuated 8.93% from a day low at $13.05 to a day high of $14.22. The price has risen in 6 of the last 10 days and is up by 12.22% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 29 thousand more shares were traded than the day before. In total, 193 thousand shares were bought and sold for approximately $2.71 million.

Given the current short-term trend, the stock is expected to fall -49.58% during the next 3 months and, with a 90% probability hold a price between $5.40 and $7.08 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LYEL Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 21.02%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lyell Immunopharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.57. On a fall, the stock will find some support from the short-term average at $12.99. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Lyell Immunopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.74 and $12.57. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Lyell Immunopharma, Inc. finds support just below today's level at $12.74. If this is broken, then the next support from accumulated volume will be at $12.57 and $11.61.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.17 between high and low, or 8.93%. For the last week, the stock has had daily average volatility of 11.14%.

Our recommended stop-loss: $13.49 (-3.96%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (LYEL) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Lyell Immunopharma, Inc. to open at $13.77, and during the day (based on 14 day Average True Range), to move between $13.42 and $14.68, which gives a possible trading interval of +/-$1.27 (+/-9.47%) up or down from last closing price. If Lyell Immunopharma, Inc. takes out the full calculated possible swing range there will be an estimated 9.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.89 (5.98%) than the support at $12.74 (9.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Lyell Immunopharma, Inc. stock A Buy?

Lyell Immunopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.443 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $13.77 ( 1.98%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk